Senior Cochlear executive Michael Kavanagh named Nanosonics CEO

By Dylan Bushell-Embling
Wednesday, 28 August, 2013

Nanosonics has tapped senior Cochlear executive Michael Kavanagh to become its next CEO.

Kavanagh will take the roles of CEO and president effective 21 October. He has been serving on the Nanosonics board since July last year.

Kavanagh is currently Cochlear’s senior vice president of global marketing. He has been working at the hearing aid implant company for 10 years and in the healthcare industry for the past 20.

“The last 12 months as a non-executive director has afforded me the opportunity to get to know the business, the talent and commitment of the team that’s in place and the nature of the global opportunity for the organisation,” he said.

Nanosonics’ current CEO, Ron Weinberger, will stay on with the company in the newly created role of president of technology development and commercialisation. He will also maintain a seat on the board of directors.

Nanosonics has been busy expanding its reach for flagship product Trophon EPR, an ultrasound probe disinfection cabinet system. In April, the company revealed it had doubled the number of probes certified for compatibility with the system.

That month, the company signed on a new UK distributor for Trophon EPR but revealed plans to also continue selling the cabinets into the market directly.

Related News

Billion-dollar deal for UQ's molecular clamp vaccine tech

Sanofi has entered into an agreement to acquire Vicebio, a biotech company formed in 2018 to...

Director of scandal-ridden Forensic Science Queensland resigns

Dr Linzi Wilson-Wilde resigned from her position one month after being suspended by Queensland...

$492m pathology hub coming to Westmead Health Precinct

The NSW Health Pathology Statewide Hub will be delivered to Westmead Health Precinct, as part of...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd